{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:04:48Z","timestamp":1776755088407,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijpharm.2016.03.045","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T06:30:24Z","timestamp":1458887424000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-\u03b5-caprolactone nanoparticles"],"prefix":"10.1016","volume":"504","author":[{"given":"Iman S.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"El-Hosary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa M.","family":"Abd-Rabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"G. Elkhateeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Nour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.03.045_bib0005","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0010","series-title":"Proceedings of the 5th International Conference on Nanotechnology: Fundamentals and Applications. Paper 202","article-title":"Preparation and in-vitro evaluation of poly-\u03b5-caprolactone nanoparticles containing atorvastatin calcium","author":"Ahmed","year":"2014"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13318-014-0183-z","article-title":"Effect of vitamin D on bioavailability and lipid lowering efficacy of simvastatin","volume":"40","author":"Al-Asmari","year":"2015","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejps.2011.08.001","article-title":"Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats","volume":"44","author":"Anwar","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(99)00058-2","article-title":"Modeling of drug release from swellable polymers","volume":"49","author":"Brazel","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/js950474+","article-title":"Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers","volume":"85","author":"Calvo","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2013.01.028","article-title":"Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products","volume":"444","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0040","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.biomaterials.2013.01.084","article-title":"Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery","volume":"34","author":"Cheng","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0009-9236(96)90218-0","article-title":"Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects","volume":"60","author":"Cilla","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamics and pharmacokinetic properties of statins","volume":"84","author":"Corsini","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/cryo.1994.1043","article-title":"Is vitrification sufficient to preserve liposomes during freeze-drying?","volume":"31","author":"Crowe","year":"1994","journal-title":"Cryobiology"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1208\/s12249-010-9382-3","article-title":"Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying","volume":"11","author":"Date","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0065","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s11095-013-1122-4","article-title":"Targeted delivery of nano-therapeutics for major disorders of the central nervous system","volume":"30","author":"Gao","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for precision in reporting particle size parameters","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1248\/cpb.c14-00030","article-title":"Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus\u00ae by spray drying technique","volume":"62","author":"Ha","year":"2014","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0080","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1016\/j.biomaterials.2012.07.063","article-title":"Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs","volume":"33","author":"He","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0168-3659(99)00253-9","article-title":"The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug","volume":"65","author":"Hombreiro P\u00e9rez","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0090","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3109\/03639045.2011.645830","article-title":"Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation","volume":"38","author":"Jiang","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0021-9150(99)00339-1","article-title":"Regression of poloxamer 407-induced atherosclerotic lesions in C57BL\/6 mice using atorvastatin","volume":"149","author":"Johnston","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1208\/s12249-011-9673-3","article-title":"Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation","volume":"12","author":"Khan","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijpharm.2008.04.006","article-title":"Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process","volume":"359","author":"Kim","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejpb.2008.01.007","article-title":"Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process","volume":"69","author":"Kim","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0142-9612(00)00292-1","article-title":"Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(e-caprolactone) as novel anticancer drug carriers","volume":"22","author":"Kim","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2005.12.003","article-title":"Critical freezing rate in freeze drying nanocrystal dispersions","volume":"111","author":"Lee","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0130","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003088-200342130-00005","article-title":"Clinical pharmacokinetics of atorvastatin","volume":"42","author":"Lennern\u00e4s","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0135","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/03639045.2012.699067","article-title":"Preparation, characterization, stability and in-vitro-in-vivo evaluation of pellet-layered simvastatin nanosuspensions","volume":"39","author":"Luo","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nano.2009.04.008","article-title":"Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery","volume":"6","author":"Mishra","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(00)00586-X","article-title":"Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450","volume":"211","author":"Mountfield","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0150","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3109\/03639049809097269","article-title":"Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers","volume":"24","author":"Naini","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2008.08.021","article-title":"Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug","volume":"133","author":"Nassar","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02652049809006840","article-title":"Influence of the stabilizer coating layer on the purification and freeze-drying of poly(d,l-lactic acid) nanoparticles prepared by an emulsion-diffusion technique","volume":"15","author":"Quintanar-Guerrero","year":"1998","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejpb.2008.03.019","article-title":"Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration","volume":"70","author":"Ren","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0939-6411(00)00125-9","article-title":"Freeze-drying of polycaprolactone and poly(d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs","volume":"50","author":"Saez","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamics properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/rcm.3403","article-title":"Liquid chromatography\/mass spectrometric studies on atorvastatin and its stress degradation products","volume":"22","author":"Shah","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0200","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1166\/jnn.2014.8901","article-title":"Polymer conjugate-based nanomaterials for drug delivery","volume":"14","author":"Tran","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","article-title":"Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products","volume":"364","author":"Van Eerdenbrugh","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.03.045_bib0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.carbpol.2012.01.051","article-title":"Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants","volume":"88","author":"Varshosaz","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0163-7258(03)00055-X","article-title":"The lipid and non-lipid effects of statins","volume":"99","author":"Wierzbicki","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0220","doi-asserted-by":"crossref","first-page":"386230","DOI":"10.1155\/2012\/386230","article-title":"The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects","volume":"2012","author":"Xu","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2016.03.045_bib0225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2009.02.015","article-title":"Micronization of atorvastatin calcium by antisolvent precipitation process","volume":"374","author":"Zhang","year":"2009","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731630254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731630254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T02:55:19Z","timestamp":1536893719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731630254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S037851731630254X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.045","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-\u03b5-caprolactone nanoparticles","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}